Guinea-Bissau stops vaccine study funded by Trump administration
Guinea-Bissau stops vaccine study funded by Trump administration is drawing significant interest across the industry.
Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis B vaccine, including any links to autism.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- US administration ordered by US International Trade Court to refund companies' tariffs imposed by Donald Trump
- Supreme Court Struck Down Trump’s Tariffs. Now Comes the Hard Work of Issuing Refunds
- Delhi Minister Ashish Sood interacts with 100 student startups, vows to unveil new policy
- SLEEK EV Secures First Closing of US$8.5 Million in Series A funding led by KYMCO Capital, with earlier participation from January Capital, Krungsri Finnovate and ORZON Ventures
Source: Original →